This article is more than 5 years old. Information may no longer be current.

VIDEO: Number of presentations highlight pituitary disorders

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — Laurence Katznelson, MD, an Endocrine Today Editorial Board member and endocrinologist from Stanford University, gives his perspective on a number of presentations and posters involving pituitary diseases.

According to Katznelson, a new medication, pasireotide, was able to control adrenocorticotropic hormone and tumor size in patients with Nelson’s syndrome. Currently, there are no real medical therapies available for the disease.

Katznelson was also interested in a presentation on the use of the new oral octreotide capsule and its effect on patients with Cushing’s disease. The drug will soon be reviewed by the FDA and more information about its use and availability is expected.